{
  "docId": "019de072-9664-765c-aed1-7258b79177ce",
  "docSlug": "6ed2ec9316cb33af47e796240bef9e8e",
  "documentTitle": "AbCellera | Results Presentation Deck | 14 slides",
  "authorId": "abcellera",
  "authorName": "AbCellera",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 4,
  "pageCount": 14,
  "prevPage": 3,
  "nextPage": 5,
  "slideType": "propose_solution",
  "function": "present_solution",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a Venn-diagram-like structure to represent the 'IND Engine' as the central hub of the drug development process.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-9664-765c-aed1-7258b79177ce/4",
  "deckHref": "/decks/019de072-9664-765c-aed1-7258b79177ce",
  "deckJsonHref": "/decks/019de072-9664-765c-aed1-7258b79177ce.json",
  "deckAnchorHref": "/decks/019de072-9664-765c-aed1-7258b79177ce#slide-4",
  "components": [
    {
      "bbox": {
        "h": 0.218,
        "w": 0.265,
        "x": 0.712,
        "y": 0.128
      },
      "kind": "callout",
      "text": "2x faster\nsolve the unsolvable\nhighest quality\nunprecedented scale",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d6ffe59f-1c71-406d-b0d1-79aadf18ad3b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.662,
        "w": 0.433,
        "x": 0.292,
        "y": 0.338
      },
      "kind": "diagram",
      "text": "IND Engine",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "50250806-91ef-4208-9644-ed01217992cb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.25,
        "x": 0.719,
        "y": 0.518
      },
      "kind": "list",
      "text": "COMPOSITION OF MATTER: Patentable DNA sequence of the drug\nIND: Investigational New Drug Application\nDRUG SUBSTANCE: GMP material for clinical testing",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2e7afe04-f0ab-4c6b-b8ae-b244646e8bc2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.6,
        "x": 0.08,
        "y": 0.1
      },
      "kind": "title",
      "text": "THE BEST CAPABILITIES IN THE WORLD FROM TARGET TO IND",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "691cd43c-3284-4c5b-8c04-55353c704084",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "process",
      "slug": null,
      "matchId": "bd2d0ab4-bde3-48e3-85eb-7ddd89b729c4",
      "evidence": "The slide depicts a linear flow from Targets/Specifications through an Engine to final outputs.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 5,
      "from": 4,
      "beatId": "81adc5db-259a-40f6-9395-de2f8729ced1",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Need",
      "beatSlug": "monroes-sequence-need",
      "evidence": "The presentation highlights the company's capabilities and deal structures to address a need",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 10,
      "from": 3,
      "name": "Logic Chain",
      "slug": "01-logic-chain",
      "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
      "matchId": "4575b066-2b5b-4477-b7aa-44021f2b6cb6",
      "evidence": "The presentation provides a clear logic chain from strong results to diversified capabilities",
      "position": 0,
      "objective": "To demonstrate the company's strong results and capabilities",
      "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
      "confidence": 0.7,
      "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
    },
    {
      "to": 5,
      "from": 4,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "0897ca0f-34d3-473f-b2bf-0935e13ef129",
      "evidence": "The presentation implies the cost of inaction by highlighting the company's deal structures",
      "position": 1,
      "objective": "To highlight the importance of the company's capabilities",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}